Salbutamol inhaler
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Salbutamol inhaler, covering 2026-01-12 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma [Phase 3]